These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 20840666)

  • 21. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
    Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection.
    Lazarovits AI; Rochon J; Banks L; Hollomby DJ; Muirhead N; Jevnikar AM; White MJ; Amlot PL; Beauregard-Zollinger L; Stiller CR
    J Immunol; 1993 Jun; 150(11):5163-74. PubMed ID: 7684422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-CD44 monoclonal antibody inhibits heart transplant rejection mediated by alloantigen-primed CD4(+) memory T cells in nude mice.
    Wang F; Chen J; Shao W; Xie B; Wang Y; Lan T; Thorlacius H; Qi Z
    Immunol Invest; 2010; 39(8):807-19. PubMed ID: 20718664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolated peripheral T cells from GvHR recipients exhibit defective IL-2R expression, IL-2 production, and proliferation in response to activation stimuli.
    Levy RB; Jones M; Cray C
    J Immunol; 1990 Dec; 145(12):3998-4005. PubMed ID: 1979582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in tumor necrosis factor-alpha mRNA but not perforin mRNA expression in response to two newly characterized anti-LFA-1 monoclonal antibodies.
    Hommel-Berrey G; Bochan M; Brahmi Z
    Nat Immun; 1994; 13(6):301-14. PubMed ID: 7894201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of proliferation and differentiation during early T cell development by anti-transferrin receptor antibody.
    Brekelmans P; van Soest P; Leenen PJ; van Ewijk W
    Eur J Immunol; 1994 Nov; 24(11):2896-902. PubMed ID: 7957580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of T cell activation by monoclonal antibodies specific for the transferrin receptor.
    Cano E; Pizarro A; Redondo JM; Sánchez-Madrid F; Bernabeu C; Fresno M
    Eur J Immunol; 1990 Apr; 20(4):765-70. PubMed ID: 2140787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
    Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
    Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-LFA-1 antibody postpones T-cell receptor triggering while preserving generation of regulatory T cells in T-cell receptor anti-HY transgenic mice.
    Go S; Fleischmann A; Lantz O; Cretolle C; Brousse N; Cerf-Bensussan N; Sarnacki S
    Transplantation; 2006 Jul; 82(1):119-26. PubMed ID: 16861951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolongation of rat cardiac allograft survival by a monoclonal antibody: anti-rat intercellular adhesion molecule-1.
    Kobayashi H; Miyano T; Yamataka A; Yamataka T; Yagita H; Eto H; Ligo Y; Tansyo S; Kojima Y; Tamatani T
    Cardiovasc Surg; 1993 Oct; 1(5):577-82. PubMed ID: 7915626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of heat-stable antigen on tumor cells provides co-stimulation for tumor-specific T cell proliferation and cytotoxicity in mice.
    Wang YC; Zhu L; McHugh R; Sell KW; Selvaraj P
    Eur J Immunol; 1995 May; 25(5):1163-7. PubMed ID: 7774619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells.
    May KF; Chen L; Zheng P; Liu Y
    Cancer Res; 2002 Jun; 62(12):3459-65. PubMed ID: 12067989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naive human T-cells become non-responsive towards anti-TNFalpha (infliximab) treatment in vitro if co-stimulated through CD28.
    Gunnlaugsdottir B; Skaftadottir I; Ludviksson BR
    Scand J Immunol; 2008 Dec; 68(6):624-34. PubMed ID: 19000096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake of 111In-labeled fully human monoclonal antibody TSP-A18 reflects transferrin receptor expression in normal organs and tissues of mice.
    Sugyo A; Tsuji AB; Sudo H; Nomura F; Satoh H; Koizumi M; Kurosawa G; Kurosawa Y; Saga T
    Oncol Rep; 2017 Mar; 37(3):1529-1536. PubMed ID: 28184946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibody.
    Callens C; Moura IC; Lepelletier Y; Coulon S; Renand A; Dussiot M; Ghez D; Benhamou M; Monteiro RC; Bazarbachi A; Hermine O
    Leukemia; 2008 Jan; 22(1):42-8. PubMed ID: 17898788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of human smooth muscle cell proliferation and transplant vasculopathy induced by HLA class I antibodies: in vitro and in vivo studies.
    Trayssac M; Nègre-Salvayre A; Thomsen M
    Hum Immunol; 2012 Dec; 73(12):1253-60. PubMed ID: 22789624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier.
    Couch JA; Yu YJ; Zhang Y; Tarrant JM; Fuji RN; Meilandt WJ; Solanoy H; Tong RK; Hoyte K; Luk W; Lu Y; Gadkar K; Prabhu S; Ordonia BA; Nguyen Q; Lin Y; Lin Z; Balazs M; Scearce-Levie K; Ernst JA; Dennis MS; Watts RJ
    Sci Transl Med; 2013 May; 5(183):183ra57, 1-12. PubMed ID: 23636093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of the human transferrin receptor and use of anti-transferrin receptor antibodies to detect tumours in vivo.
    Panaccio M; Zalcberg JR; Thompson CH; Leyden MJ; Sullivan JR; Lichtenstein M; McKenzie IF
    Immunol Cell Biol; 1987 Dec; 65 ( Pt 6)():461-72. PubMed ID: 2452131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion of an anti-transferrin receptor antibody in cultured murine melanoma cell layers.
    Vijaykumar V; Topp EM
    Pharm Res; 1995 Dec; 12(12):1907-16. PubMed ID: 8786965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.